A national, matched, test-negative, case-control study assessing the effects of previous infection and vaccination on symptomatic Omicron Infections
Latest Information Update: 20 Jun 2022
At a glance
- Drugs Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 20 Jun 2022 New trial record
- 15 Jun 2022 Results published in the New England Journal of Medicine